News About: R&D
Cell injections accelerate healing of oral-maxillofacial injuries
The injection of bone-building cells has proven to help oral and maxillofacial injuries and defects heal faster, according to Sewon Cellontech.
The company said that Ossron, an autologous biologic product containin...
Korean scientists claim new alcoholic fatty liver drug possible
Korean scientists claim to have developed a natural drug derived from magnolia extracts (SPA002 and SPA005) that they say could bring innovations in the treatment of alcohol-induced liver disease.
In a study publis...
Korean companies trying to tap huge obesity market with natural drugs
Obesity problem is on a rise and more and more people are using medication to aid in weight loss, including the me-too products of Reductil as well as other prescription only slimming pills. Nevertheless, obesity figu...
Oscotec files IND application to US FDA
Oscotec Inc. said it has filed an application of its osteoarthritis medicine OCT-1547 to the US Food and Drug Administration and EMCA in Europe, it was announced on March 19.
OCT-1547 inhibits the differentiation a...
KIT to conduct large-scale preclinical tests over antisense oligonucleotides
The Korea Institute of Toxicology (KIT) said on March 16 that KIT will carry out its preclinical studies for the US based ISIS Pharmaceuticals Inc’s antisense oligonucleotides (ASO) using non-human primates.
Both o...
Government to inject 16.7 billion won into new oriental medicine development projects
The Ministry of Health, Welfare and Family Affairs has announced that it will inject 16.7 billion won next year into projects aimed at developing new natural medicines based on established formulation of oriental medi...
Generic testing helpful to prediction of initial dose of warfarin
An algorithm incorporating genetic information is helpful in predicting the appropriate initial dose of warfarin in patients who are "outliers" - that is, those who require either higher- or lower-than-average doses o...
Korea Stem Cell Bank commercializes stem cell expansion technology
The Korea Stem Cell Bank says that adult stem cells can be harvested from a filtered extraction of the patient's own blood and grown to larger, therapeutic quantities eliminating the most critical problem in conventio...
Lucentis therapy is superior to verteporfin photodynamic therapy
The 2-year results of the ANCHOR clinical trial indicate that Lucentis therapy for age-related macular degeneration (AMD) with new-onset, predominantly classic choroidal neovascularization (CNV) is superior to vertepo...
Korea’s 400 papers published in world’s leading journals last year
Korean scientists published a total of 400 theses with impact factor of more than 10 last year, according to the Biological Research Information Center.
24 papers were posted on Nature, the world’s leading journal,...
